Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve System (MINERVA FIH)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04775108
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:38.802846+00:00
Published At
2023-08-07T00:00:00+00:00
Record Updated At
2023-08-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Mitral Valve Regurgitation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-07"
protocolSection.identificationModule.nctId
"NCT04775108"
protocolSection.identificationModule.officialTitle
"First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon\u2122 TRanscatheter Mitral VAlve System (MINERVA FIH)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Mitral Valve Regurgitation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.